TITLE:
Treatment Satisfaction with Insulin Glargine in Insulin-Naïve Type 2 Diabetes Patients—A Hong Kong Based Registry
AUTHORS:
Wing-Bun Chan, Wilson W. M. Ngai, Peter Chun-Yip Tong
KEYWORDS:
Insulin Glargine, Patient Satisfaction, Hong Kong, Type 2 Diabetes Mellitus
JOURNAL NAME:
Journal of Diabetes Mellitus,
Vol.4 No.3,
August
21,
2014
ABSTRACT: Objective: To evaluate
patient satisfaction with insulin glargine. Design: Multicentre observational
registry. Data were collected at baseline/inclusion visit, and 12 and 24 weeks.
Setting: Physicians in Hong Kong, who managed type 2 diabetes patients and had
>5 years’ experience in using insulin glargine. Patients: People with type 2
diabetes, new to insulin, aged 18 - 75 years, who were previously being treated
with ≤3 oral antidiabetes drugs (OAD) and had HbA1c > 7%, and in whom thephysicians had chosen to prescribe
glargine for the first time. Main outcome measures: Treatment satisfaction
assessed by Diabetes Treatment Satisfaction Questionnaire (DTSQs), glycaemic
control (fasting blood glucose and HbA1c) and adverse events. Results: Between
April 2010-October 2011, 41 patients completed the study. Average duration of
diabetes and OAD therapy was 7.8 ± 8.0 years and 6.7 ± 7.4 years, respectively.
The global DTSQs treatment satisfaction scores improved from 20.9 at baseline
to 28.4 (p